RiverPark Advisors »

Ligand Pharmaceuticals In shares owned by RiverPark Advisors

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by RiverPark Advisors from 13F filings

Historical chart of RiverPark Advisors investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by RiverPark Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by RiverPark Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $432k 1.4k 316.09
2026-03-31 $132k 659 199.65

More positions owned by RiverPark Advisors

Ziff Davis Note 1.750%11/0 (Principal)
Inflection Pt Acquisition Cl A Ord Shs (IPCX)
Soulpower Acquisition Corp Usd Cl A Ord Shs (SOUL)
Silverbox Corp Iv Shs Cl A (SBXD)
Sizzle Acquisition Corp. Ii Usd Cl A Ord Shs (SZZL)
Apple (AAPL)
Fifth Era Acquisition Corp I Ord Shs Cl A (FERA)
Taiwan Semiconductor Manufacturing Sponsored Ads (TSM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Kochav Defense Acqui Shs Cl A (KCHV)
Churchill Capital Corp Ix Cl A Shs (CCIX)
Cantor Equity Partners I Shs Cl A (CEPO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for RiverPark Advisors

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Portfolio Management
Henderson Group
Vanguard Capital Management
Invesco
State Street Corporation
Congress Asset Management
FMR
Nomura Asset Management International
Franklin Resources
Geode Capital Management
Chicago Capital
Stephens Investment Management Group
Dimensional Fund Advisors
Massachusetts Financial Services

View all funds holding Ligand Pharmaceuticals In